These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 32266599

  • 1. Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates.
    Mulubwa M, Griesel HA, Mugabo P, Dippenaar R, van Wyk L.
    Drugs R D; 2020 Jun; 20(2):105-113. PubMed ID: 32266599
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target.
    Bhongsatiern J, Stockmann C, Roberts JK, Yu T, Korgenski KE, Spigarelli MG, Desai PB, Sherwin CM.
    Ther Drug Monit; 2015 Dec; 37(6):756-65. PubMed ID: 26562817
    [Abstract] [Full Text] [Related]

  • 4. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
    Abdel Hadi O, Al Omar S, Nazer LH, Mubarak S, Le J.
    J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N, Tang L, Phelps SJ, Meibohm B.
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [Abstract] [Full Text] [Related]

  • 9. Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination.
    Lo YL, van Hasselt JG, Heng SC, Lim CT, Lee TC, Charles BG.
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2626-32. PubMed ID: 20385872
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Optimization of Intermittent Vancomycin Dosage Regimens for Thai Critically Ill Population Infected by MRSA in the Era of the "MIC Creep" Phenomenon.
    Setiawan E, Suwannoi L, Montakantikul P, Chindavijak B.
    Acta Med Indones; 2019 Jan; 51(1):10-18. PubMed ID: 31073101
    [Abstract] [Full Text] [Related]

  • 13. Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: Is It Time for a New Dosing Regimen?
    Kontou A, Sarafidis K, Begou O, Gika HG, Tsiligiannis A, Ogungbenro K, Dokoumetzidis A, Agakidou E, Roilides E.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31932366
    [Abstract] [Full Text] [Related]

  • 14. Inadequate vancomycin therapy in term and preterm neonates: a retrospective analysis of trough serum concentrations in relation to minimal inhibitory concentrations.
    Sinkeler FS, de Haan TR, Hodiamont CJ, Bijleveld YA, Pajkrt D, Mathôt RA.
    BMC Pediatr; 2014 Jul 28; 14():193. PubMed ID: 25066951
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Optimisation of vancomycin exposure in neonates based on the best level of evidence.
    Dao K, Guidi M, André P, Giannoni E, Basterrechea S, Zhao W, Fuchs A, Pfister M, Buclin T, Csajka C.
    Pharmacol Res; 2020 Apr 28; 154():104278. PubMed ID: 31108184
    [Abstract] [Full Text] [Related]

  • 18. Use of Monte Carlo simulation to evaluate the development of vancomycin resistance in meticillin-resistant Staphylococcus aureus.
    Mei Q, Ye Y, Zhu YL, Cheng J, Yang HF, Liu YY, Li HR, Li JB.
    Int J Antimicrob Agents; 2015 Jun 28; 45(6):652-6. PubMed ID: 25813394
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.
    Lim HS, Chong YP, Noh YH, Jung JA, Kim YS.
    J Clin Pharm Ther; 2014 Apr 28; 39(2):196-203. PubMed ID: 24428720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.